A brief overview of SARS-CoV-2 infection and its management strategies: a recent update
Open Access
- 24 September 2023
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 479 (9) , 2195-2215
Abstract
The COVID-19 pandemic has become a global health crisis, inflicting substantial morbidity and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and fatigue, characterizes COVID-19. A cytokine surge can exacerbate the disease’s severity. This phenomenon involves an increased immune response, marked by the excessive release of inflammatory cytokines like IL-6, IL-8, TNF-α, and IFNγ, leading to tissue damage and organ dysfunction. Efforts to reduce the cytokine surge and its associated complications have garnered significant attention. Standardized management protocols have incorporated treatment strategies, with corticosteroids, chloroquine, and intravenous immunoglobulin taking the forefront. The recent therapeutic intervention has also assisted in novel strategies like repurposing existing medications and the utilization of in vitro drug screening methods to choose effective molecules against viral infections. Beyond acute management, the significance of comprehensive post-COVID-19 management strategies, like remedial measures including nutritional guidance, multidisciplinary care, and follow-up, has become increasingly evident. As the understanding of COVID-19 pathogenesis deepens, it is becoming increasingly evident that a tailored approach to therapy is imperative. This review focuses on effective treatment measures aimed at mitigating COVID-19 severity and highlights the significance of comprehensive COVID-19 management strategies that show promise in the battle against COVID-19.Keywords
Funding Information
- University of Oslo
This publication has 181 references indexed in Scilit:
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013
- Electrochemical Immunosensors for Detection of Cancer Protein BiomarkersACS Nano, 2012
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 2011
- The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health statusRespirology, 2010
- Interleukin-1β (IL-1β) Processing PathwayScience Signaling, 2010
- HLA–B27 misfolding and the unfolded protein response augment interleukin‐23 production and are associated with Th17 activation in transgenic ratsArthritis & Rheumatism, 2009
- In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortexJournal of Clinical Virology, 2008
- Interleukin 6: from bench to bedsideNature Clinical Practice Rheumatology, 2006
- Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivorsThorax, 2005
- Is selection for TCR affinity a factor in cytokine polarization?Trends in Immunology, 2002